CY1622A - Pharmaceutical formulations with controlled release of the active substance - Google Patents

Pharmaceutical formulations with controlled release of the active substance

Info

Publication number
CY1622A
CY1622A CY1622A CY162292A CY1622A CY 1622 A CY1622 A CY 1622A CY 1622 A CY1622 A CY 1622A CY 162292 A CY162292 A CY 162292A CY 1622 A CY1622 A CY 1622A
Authority
CY
Cyprus
Prior art keywords
active substance
controlled release
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
CY1622A
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1622A publication Critical patent/CY1622A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
CY1622A 1985-10-01 1992-07-10 Pharmaceutical formulations with controlled release of the active substance CY1622A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions
GB8623389A GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance

Publications (1)

Publication Number Publication Date
CY1622A true CY1622A (en) 1992-07-10

Family

ID=27546915

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1622A CY1622A (en) 1985-10-01 1992-07-10 Pharmaceutical formulations with controlled release of the active substance

Country Status (2)

Country Link
CY (1) CY1622A (en)
GB (1) GB2181053B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
ATE71833T1 (en) * 1986-11-03 1992-02-15 Schering Corp LABETALOL DELAYED-RELEASE TABLET.
SI8710406B (en) * 1987-03-11 1998-08-31 Lek Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
FR2677886B1 (en) * 1991-06-18 1995-03-31 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF INDAPAMIDE AFTER ORAL ADMINISTRATION.
EP2543364A1 (en) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2441446A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617393C2 (en) * 1966-01-06 1982-11-11 Československá akademie věd, Praha Process for the preparation of hydrophilic crosslinked copolymers containing biologically active substances
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
GB2181053A (en) 1987-04-15
GB2181053B (en) 1990-05-23
GB8623389D0 (en) 1986-11-05

Similar Documents

Publication Publication Date Title
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
GB2211413B (en) Pharmaceutical formulations comprising microcapsules
EP0282951A3 (en) Controlled release preparations of active materials
GB8502974D0 (en) Sustained release of active substance
GB8504099D0 (en) Physiologically active substances
GB8630870D0 (en) Active support substance
PH20391A (en) Controlled release pharmaceutical preparations
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
NO862373D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIENOPYRIDONES.
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
GR862457B (en) Pharmaceutical formulations with controlled release of the active substance
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
GB8901833D0 (en) Pharmaceutical formulations with controlled drug release
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
ZA86705B (en) Controlled release insecticide
ZA875937B (en) Pharmaceutical formulations comprising microcapsules
IE850071L (en) Controlled release pharmaceutical formulations
GB8503221D0 (en) Pharmaceutical formulations
IT8648494A0 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF THE ACTIVE SUBSTANCE
HUT43925A (en) Insecticides comprising trihalogen-imidazole derivatives as active substance and process for preparing the active substances
EG17797A (en) Controlled release formulation
IL68779A0 (en) Pharmaceutical mixture with controlled release of active substance